The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
32 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,462,841 in first-year total cost, median $231,446.
Most frequent study sections
- Special Emphasis Panel[ZRG1 AARR-K (51)]24
- Special Emphasis Panel[ZAI1 JRR-A (S4)]8
Most frequent institutions
- TULANE UNIVERSITY OF LOUISIANA3
- CASE WESTERN RESERVE UNIVERSITY2
- FRED HUTCHINSON CANCER RESEARCH CENTER2
- MASSACHUSETTS GENERAL HOSPITAL2
- UNIVERSITY OF MICHIGAN AT ANN ARBOR2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2014 | Curing HIV Through Allogeneic Hematopoietic Stem Cell Transplantation1R21AI116184-01 | KEAN, LESLIE S | SEATTLE CHILDREN'S HOSPITAL, WA | $323,513 | ZRG1 |
| 2014 | Specific activation of latent HIV-1 by inhibiting E3 ubiquitin ligase activity1R21AI110166-01 | DOUGHERTY, JOSEPH | RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL, NJ | $315,279 | ZAI1 |
| 2014 | Characterization of follicular dendritic cells as a reservoir for HIV1R21AI110164-01A1 | CARROLL, MICHAEL CRAIG | BOSTON CHILDREN'S HOSPITAL, MA | $263,875 | ZRG1 |
| 2014 | Cell-Based Secretion of Antiviral Molecules as a Treatment for HIV-AIDS1R21AI110154-01 | KIEM, HANS-PETER | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $259,621 | ZAI1 |
| 2014 | Alpha Emitter Labeled Anti-T Cell Antibody: Targeting Latent HIV Infected Cells1R21AI116225-01 | SANDMAIER, BRENDA MARIE | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $256,599 | ZRG1 |
| 2014 | Targeting SIV reservoirs with type I Interferons1R21AI116200-01 | SILVESTRI, GUIDO | EMORY UNIVERSITY, GA | $255,794 | ZRG1 |
| 2014 | Suppressing the latent reservoir with a Tat inhibitor1R21AI116226-01 | VALENTE, SUSANA T | SCRIPPS FLORIDA, FL | $255,150 | ZRG1 |
| 2014 | Adipose Tissue is a significant reservoir for HIV1R21AI116208-01 | BALASUBRAMANYAM, ASHOKLEWIS, DOROTHY E. | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $252,313 | ZRG1 |
| 2014 | Effective lethal agents for CCR5???expressing cells1R21AI116230-01 | HARTIGAN-O'CONNOR, DENNIS J. | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $251,938 | ZRG1 |
| 2014 | Evaluating HIV expression and latency in blood and tissues at the single cell level1R21AI116218-01 | WONG, JOSEPH K | NORTHERN CALIFORNIA INSTITUTE/RES/EDU, CA | $246,906 | ZRG1 |
| 2014 | Therapeutic vaccination targeting SIV viral reservoirs1R21AI116211-01 | VEZYS, VAIVA D | UNIVERSITY OF MINNESOTA, MN | $240,193 | ZRG1 |
| 2014 | Targeting HIV-1 persistence with Interferon-a1R21AI116228-01 | YU, XU | MASSACHUSETTS GENERAL HOSPITAL, MA | $239,250 | ZRG1 |
| 2014 | Role of P-TEFB in HIV latency1R21AI116173-01 | RICE, ANDREW P | BAYLOR COLLEGE OF MEDICINE, TX | $236,491 | ZRG1 |
| 2014 | Inhibiting Immune Evasion by HIV-1 Nef to Facilitate Eradication1R21AI110162-01 | GUATELLI, JOHN C. | VETERANS MEDICAL RESEARCH FDN/SAN DIEGO, CA | $236,345 | ZAI1 |
| 2014 | Killing the Reservoir with Antibodies1R21AI110165-01 | ALTER, GALIT | MASSACHUSETTS GENERAL HOSPITAL, MA | $235,561 | ZAI1 |
| 2014 | Targeting Cytolytic Cells to Lymphoid Sites of HIV Persistence.1R21AI116171-01 | LEDERMAN, MICHAEL MARCELPAIARDINI, MIRKO | CASE WESTERN RESERVE UNIVERSITY, OH | $234,742 | ZRG1 |
| 2014 | Targeting Macrophage Reservoirs in the Macaque Model of Pediatric AIDS1R21AI116198-01 | KURODA, MARCELO J | TULANE UNIVERSITY OF LOUISIANA, LA | $228,150 | ZRG1 |
| 2014 | Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin1R21AI116205-01 | HENRICH, TIMOTHY JENSEN | BRIGHAM AND WOMEN'S HOSPITAL, MA | $224,439 | ZRG1 |
| 2014 | Targeting HIV Lung Reservoir in the Macaque Model1R21AI110163-01 | KURODA, MARCELO J | TULANE UNIVERSITY OF LOUISIANA, LA | $222,698 | ZAI1 |
| 2014 | Novel flow cytometry-based assay for HIV-infected cells1R21AI110143-01 | MCCUNE, JOSEPH M | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $220,601 | ZAI1 |
| 2014 | Kinomic analysis of host cell factors controlling latent HIV-1 infection1R21AI116188-01 | KUTSCH, OLAF | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $220,500 | ZRG1 |
| 2014 | An ex vivo model to predict outcomes and probe mechanism of anti-reservoir agents1R21AI116216-01 | O'DOHERTY, UNA T | UNIVERSITY OF PENNSYLVANIA, PA | $220,000 | ZRG1 |
| 2014 | Novell small molecules to reactivate latent HIV and sensitize to anti-viral therapies1R21AI116222-01 | D'ORSO, IVANMARTINEZ, ELISABETH D | UT SOUTHWESTERN MEDICAL CENTER, TX | $218,625 | ZRG1 |
| 2014 | HIV eradication by ADCC-activated NK cell killing1R21AI110156-01 | KARN, JONATHAN | CASE WESTERN RESERVE UNIVERSITY, OH | $217,938 | ZAI1 |
| 2014 | Lineage marking in humanized mice to reveal HIV-1 reservoirs1R21AI116191-01 | CHEN, BENJAMIN K | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $210,841 | ZRG1 |
| 2014 | HIV-specific nucleases to reservoir cells1R21AI110149-01 | CANNON, PAULA M | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $205,208 | ZAI1 |
| 2014 | Purging the latent HIV reservoir at ART initiation: A new eradication strategy1R21AI116233-01 | CHOMONT, NICOLASTRAUTMANN, LYDIE | VGTI FLORIDA, FL | $201,497 | ZRG1 |
| 2014 | A family of compounds that reactivate latent HIV without T cell activation1R21AI116212-01 | BOSQUE, ALBERTO | UNIVERSITY OF UTAH, UT | $198,800 | ZRG1 |
| 2014 | Modified CMV-specific T cells to Target HIV1R21AI110158-01A1 | BRAUN, STEPHEN EDWARD | TULANE UNIVERSITY OF LOUISIANA, LA | $198,521 | ZRG1 |
| 2014 | High throughput analysis of latency/reactivation with barcoded proviruses1R21AI116190-01 | CHANG, CHEONG-HEEKIDD, JEFFREY MTELESNITSKY, ALICE | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $194,271 | ZRG1 |
| 2014 | Cooperation of BRD4 and TAT Associated Proteins in HIV Transcription and Latency1R21AI116180-01 | ZHU, JIAN | UNIVERSITY OF ROCHESTER, NY | $190,270 | ZRG1 |
| 2014 | Development of Nef antagonists to enhance CTL clearance of HIV reservoirs1R21AI116158-01 | COLLINS, KATHLEEN L. | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $186,912 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.